Edge Wealth Management’s Traws Pharma TRAW Stock Holding History

Edge Wealth Management’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3	Closed	-$1K	–	716
2020 Q1	$1K	Buy	+3	New	+$471	﹤0.01%	611

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HWA

Hillcrest Wealth Advisors Hazlet, New Jersey $279M AUM 21.72% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAMH

Shanda Asset Management Holdings Tortola,, British Virgin Islands $1.85B AUM 36.09% 1-Year Est. Return

Quilter Plc London, United Kingdom $5.7B AUM 21.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Edge Wealth Management's TRAW Position: Q2 2020 in Review

Edge Wealth Management sold out of Traws Pharma (TRAW) in Q2 2020, closing a stake of 3 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in TRAW in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 29 funds tracked by Wall St. Rank hold TRAW as of Q2 2020.

Edge Wealth Management reported no remaining Traws Pharma position as of Q2 2020 after selling out during the quarter.
Edge Wealth Management sold 3 Traws Pharma shares in Q2 2020, an estimated $1K.
Edge Wealth Management first reported a position in Traws Pharma in Q1 2020 and held it in 1 quarter.
Edge Wealth Management's Traws Pharma position peaked at $1K in Q1 2020.
29 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2020.

Based on Edge Wealth Management's 13F filing for Q2 2020, filed 3 Aug 2020.